U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050536
Company: DR REDDYS LABS SA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ERYC ERYTHROMYCIN 250MG CAPSULE, DELAYED REL PELLETS;ORAL Prescription AB Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/26/1981 ORIG-1 Approval Type 3 - New Dosage Form STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/23/2018 SUPPL-26 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050536s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/050536Orig1s026ltr.pdf
12/19/2013 SUPPL-24 Manufacturing (CMC)

Label is not available on this site.

12/19/2013 SUPPL-23 Manufacturing (CMC)

Label is not available on this site.

02/14/2012 SUPPL-22 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050536s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050536s022ltr.pdf
03/21/2013 SUPPL-21 Labeling-Package Insert Label (PDF)
Letter (PDF)
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050536s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/050536Orig1s021ltr_corrected.pdf
02/21/2008 SUPPL-20 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050536s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050536s020ltr.pdf
01/12/2006 SUPPL-19 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050536s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/050536s019ltr.pdf
12/18/2003 SUPPL-18 Labeling Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/50536slr018ltr.pdf
02/02/2004 SUPPL-16 Labeling Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50536slr016ltr.pdf
08/05/1999 SUPPL-15 Manufacturing (CMC)-Control

Label is not available on this site.

10/21/1997 SUPPL-14 Manufacturing (CMC)-Control

Label is not available on this site.

09/22/2000 SUPPL-13 Labeling

Label is not available on this site.

03/30/1982 SUPPL-12 Manufacturing (CMC)-Expiration Date

Label is not available on this site.

01/28/1982 SUPPL-11 Manufacturing (CMC)

Label is not available on this site.

08/07/1981 SUPPL-10 Labeling

Label is not available on this site.

06/15/1981 SUPPL-9 Labeling

Label is not available on this site.

06/05/1981 SUPPL-8 Manufacturing (CMC)-Control

Label is not available on this site.

06/16/1986 SUPPL-7 Manufacturing (CMC)-Formulation

Label is not available on this site.

06/05/1981 SUPPL-6 Labeling

Label is not available on this site.

05/20/1981 SUPPL-5 Manufacturing (CMC)-Control

Label is not available on this site.

05/18/1981 SUPPL-4 Manufacturing (CMC)-Control

Label is not available on this site.

05/21/1981 SUPPL-3 Labeling

Label is not available on this site.

04/22/1981 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
04/23/2018 SUPPL-26 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050536s026lbl.pdf
03/21/2013 SUPPL-21 Labeling-Package Insert Label (PDF) Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050536s021lbl.pdf
02/14/2012 SUPPL-22 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050536s022lbl.pdf
02/21/2008 SUPPL-20 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050536s020lbl.pdf
01/12/2006 SUPPL-19 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050536s019lbl.pdf

ERYC

CAPSULE, DELAYED REL PELLETS;ORAL; 250MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ERYC ERYTHROMYCIN 250MG CAPSULE, DELAYED REL PELLETS;ORAL Prescription Yes AB 050536 DR REDDYS LABS SA
ERYTHROMYCIN ERYTHROMYCIN 250MG CAPSULE, DELAYED REL PELLETS;ORAL Prescription No AB 062746 AZURITY
Back to Top